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Abstract: Background: A valid malnutrition screening tool (MST) is essential to provide timely
nutrition support in ambulatory cancer care settings. The aim of this study is to investigate the validity
of the Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) and the new Global
Leadership Initiative on Malnutrition (GLIM) criteria as compared to the reference standard, the
Patient-Generated Subjective Global Assessment (PG-SGA). Methods: Cross-sectional observational
study including 246 adult ambulatory patients with cancer receiving in-chair intravenous treatment
at a cancer care centre in Australia. Anthropometrics, handgrip strength and patient descriptive data
were assessed. Nutritional risk was identified using MST and PG-SGA SF, nutritional status using
PG-SGA and GLIM. Sensitivity (Se), specificity (Sp), positive and negative predictive values and
kappa (k) were analysed. Associations between malnutrition and 1-year mortality were investigated
by Cox survival analyses. Results: A PG-SGA SF cut-off score ≥5 had the highest agreement when
compared with the PG-SGA (Se: 89%, Sp: 80%, k = 0.49, moderate agreement). Malnutrition risk
(PG-SGA SF ≥ 5) was 31% vs. 24% (MST). For malnutrition according to GLIM, the Se was 76%
and Sp was 73% (k = 0.32, fair agreement) when compared to PG-SGA. The addition of handgrip
strength to PG-SGA SF or GLIM did not improve Se, Sp or agreement. Of 100 patients who provided
feedback, 97% of patients found the PG-SGA SF questions easy to understand, and 81% reported
that it did not take too long to complete. PG-SGA SF ≥ 5 and severe malnutrition by GLIM were
associated with 1-year mortality risk. Conclusions: The PG-SGA SF and GLIM criteria are accurate,
sensitive and specific malnutrition screening and assessment tools in the ambulatory cancer care
setting. The addition of handgrip strength tests did not improve the recognition of malnutrition or
mortality risk.
Keywords: malnutrition; cancer; handgrip strength; nutrition assessment
1. Introduction
In 2019, it is estimated that almost 145,000 new cases of cancer will be diagnosed in Australia [1].
Throughout their cancer journey, around 30–90% of patients experience malnutrition [2,3]. This is
concerning, as malnutrition is associated with reduced treatment effectiveness [4–6], functional
status [4,6], quality of life [4,7] and survival [4–6,8]. Research suggests that early nutrition intervention
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may prevent nutritional deterioration in patients with cancer [9–11] and as such it is therefore
recommended that regular nutrition screening to facilitate timely nutrition care occurs for all patients
undergoing cancer treatment [12].
Patients with cancer often receive treatment in outpatient or ambulatory day care settings.
To identify malnutrition risk in these patients, it is essential to choose an efficient nutritional screening
tool suitable for ambulatory cancer patients. We know that many screening tools can lack clinical
information, sensitivity, specificity and/or are not usable and applicable for busy cancer care centres in
which there are high turnover rates of outpatients and limited human resources [13].
A number of malnutrition screening tools exist, with the Malnutrition Screening Tool (MST) being
the most commonly used in Australia. The MST has a good validity, sensitivity and specificity to
identify malnutrition assessed using the Patient-Generated Subjective Global Assessment (PG-SGA)
in ambulatory cancer care patients. The PG-SGA is widely used in clinical practice for assessing
nutritional status of cancer patients. The Patient-Generated Subjective Global Assessment Short Form
(PG-SGA SF), a component of the full PG-SGA, has recently been receiving new attention as a valid
screening tool for nutritional risk [14] and meets the professional standard when compared to the
PG-SGA [15,16]. The PG-SGA SF retains the patient completed section of weight history, food intake,
nutrition symptoms and physical function, and foregoes the remainder. The optimal cut-off value or
score to determine malnutrition risk according to the PG-SGA SF differs in the research and depends on
the purpose or objectives of the team using the instrument in clinical practice [17]. Since it is designed
to be completed by the patient, it is relatively simple to complete, and it reduces time and additional
burden to healthcare professionals [15]. Patient-led screening may improve patient autonomy and
aligns with the international focus on patient-centred care. Recently, patient-led screening with the
MST was found to be reliable and well accepted by patients attending an ambulatory cancer care
setting [18].
Interestingly, to standardize the clinical practice of malnutrition diagnosis in clinical settings,
the Global Leadership Initiative on Malnutrition (GLIM) recently proposed diagnostic criteria for
malnutrition. The GLIM criteria are objective, global and based on consensus. The GLIM includes a
combination of phenotypic (percentage weight loss, low body mass index, reduced muscle mass) and
etiologic (reduced food intake or assimilation, acute or chronic inflammation) criteria for the diagnosis
of malnutrition. The GLIM criteria have not yet been validated for identifying malnutrition in an
ambulatory oncology population, nor its predictive value regarding survival in these patients. There is
well established evidence of the PG-SGA’s ability to predict clinical outcomes including survival with
well-nourished oncology patients having longer survival duration than malnourished patients [14,15].
It has also been shown that handgrip strength is reduced in cancer patients with malnutrition [19].
Handgrip strength has been shown to be a prognostic marker and is positively associated with survival
duration, for instance, in older patients with cancer [20,21]. As the aim of nutritional therapy is to
restore muscle mass and muscle strength, handgrip strength can serve as an additional parameter to
improve the recognition of malnutrition risk or malnutrition. Assessment of muscle function using
grip strength is recommended as a supportive measure in the GLIM consensus [22].
Therefore, the aim of this study is to (1) evaluate the agreement, sensitivity and specificity of
the PG-SGA SF and GLIM criteria to reference standard of PG-SGA, (2) investigate the added value
of handgrip strength test to PG-SGA SF and GLIM to recognise malnutrition risk or malnutrition,
(3) evaluate the patient experience and ease of completion of the patient-completed PG-SGA SF and
(4) investigate the ability of these tools to predict patient outcomes such as mortality and hospitalisation
and whether any tool is superior in this ability.
2. Materials and Methods
We conducted a cross-sectional, observational study at the Mater Cancer Care Centre (MCCC)
in Brisbane, QLD, Australia over one week in May 2018 and repeated over one week in March 2019.
Patient outcome data were collected 12 months post initial data collection. The protocol received
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was approved as low risk research by the Human Research Ethics Committee of Mater Misericordiae
Limited (HREC/18/MHS/101).
2.1. Participants
Patients with cancer aged 18 years or older were included if they were receiving in-chair intravenous
treatment at MCCC. People who were receiving treatment for a benign condition (e.g., rheumatoid
arthritis), receiving a blood transfusion only, waiting on hospital admission, or who declined to take
part in this study were excluded from participation.
2.2. PG-SGA SF
Patients who consented to the study were asked to complete a paper-based PG-SGA SF and
received basic verbal instructions (such as ‘tick the box that is applicable’) by trained staff. The PG-SGA
SF consists of four boxes: box 1, questions regarding body weight (scored 0–5); box 2, food intake
(score 0–4); box 3, symptoms affecting oral food intake (scored 0–23); and box 4, regarding activities
and function. Based on findings from a previous Australian study [16], box 4 questions were excluded
from the PG-SGA SF used in this study. Upon completion, the scores of boxes 1, 2 and 3 were totalled
by a dietitian.
A short questionnaire to assess ease of completion and time taken to complete the PG-SGA SF was
provided to each patient in 2019. The questionnaire was based on previously developed tools [18] and
included four questions regarding clarity and understanding of the tool, and time taken to complete
the tool.
2.3. MST and PG-SGA
In line with established guidelines [12], all participants were screened for malnutrition using the
MST. The MST includes two questions about recent unintentional weight loss and reduced appetite
affecting dietary intake [23] with answers generating a numerical score between 0 and 5. Patients
with an MST score ≥2 were classified as ‘at risk of malnutrition’ and were assessed by dietitians using
the PG-SGA to determine their degree of malnutrition. The PG-SGA classifies patients into three
categories: (A) well-nourished; (B) moderately malnourished; or (C) severely malnourished. For data
analysis purposes, patients with MST <2 were assumed as well nourished (PG-SGA A).
2.4. GLIM Criteria
To diagnose malnutrition using the GLIM criteria, weight changes within six months (%) and body
mass index (BMI) were calculated using patients’ weight history and height (Table 1). Based on the GLIM
criteria, participants who had a combination of at least one phenotypic criterion (weight loss and/or
low BMI for age) and one etiologic criterion (disease burden and inflammatory condition of cancer)
were categorised as malnourished. The remaining participants were categorised as well-nourished.
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Table 1. Global Leadership Initiative on Malnutrition (GLIM) phenotypic and etiologic criteria for the
diagnosis of malnutrition.
Phenotypic Criteria Etiologic Criteria
Weight Loss (%) Low Body MassIndex (kg/m2)
Reduced Muscle
Mass a
Reduced Food
Intake or
Assimilation b,c
Inflammation d–f
>5% within past
6 months or >10%
beyond 6 months
<20 if <70 years,
or <22 if >70 years
Asia: <18.5 if
<70 years, or <20 if
>70 years
Reduced by
validated body
composition
measuring
techniques
≤50% of ER >1 week,
or any reduction for
>2 weeks, or any
chronic GI condition
that adversely
impacts food
assimilation or
absorption
Acute
disease/injury d,f or
chronic
disease-related e,f
ER = energy requirements, GI = gastrointestinal. Requires at least one phenotypic criterion and one etiologic criterion
for diagnosis of malnutrition; a for example, fat free mass index, by dual-energy absorptiometry or corresponding
standards using other body composition methods like bioelectrical impedance analysis, computed tomography
(CT) or magnetic resonance imaging (MRI). When not available or by regional preference, physical examination or
standard anthropometric measures like mid-arm muscle or calf circumference may be used. Thresholds for reduced
muscle mass need to be adapted to race (Asia). Functional assessments like hand-grip strength may be considered as
a supportive measure. b Consider gastrointestinal symptoms as supportive indicators that can impair food intake or
absorption (e.g., dysphagia, nausea, vomiting, diarrhoea, constipation or abdominal pain). Use clinical judgement
to discern severity based upon the degree to which intake or absorption are impaired. Symptom intensity, frequency
and duration should be noted. c Reduced assimilation of food/nutrients is associated with malabsorptive disorders
like short bowel syndrome, pancreatic insufficiency and after bariatric surgery. It is also associated with disorders
like esophageal stricture, gastroparesis and intestinal pseudo-obstruction. Malabsorption is a clinical diagnosis that
manifests as chronic diarrhoea or steatorrhoea. Malabsorption in those with ostomies is evidenced by elevated
volumes of output. Use clinical judgement or additional evaluation to discern severity based upon frequency,
duration and quantitation of faecal fat and/or volume of losses. d Acute disease/injury-related. Severe inflammation
is likely to be associated with major infection, burns, trauma or closed head injury. Other acute disease/injury-related
conditions are likely to be associated with mild-moderate inflammation. e Chronic disease-related conditions. Severe
inflammation is not generally associated with chronic disease conditions. Chronic or recurrent mild-moderate
inflammation is likely to be associated with malignant disease, chronic obstructive pulmonary disease, congestive
heart failure, chronic renal disease or any disease with chronic or recurrent inflammation. Note that transient
inflammation of a mild degree does not meet the threshold for this etiologic criterion. f C-reactive protein may be
used as a supportive laboratory measure.
2.5. Handgrip Strength (HGS)
Handgrip strength tests were performed in the dominant hand using a hydraulic hand
dynamometer (Jamar Plus+, Performance Health Supply Inc., Sutton-in-Ashfield, UK). The patient
performed the test in a seated position, with the shoulder abducted and neutrally rotated, elbow
flexed at 90 degrees, forearm and wrist in a neutral position. Patients were instructed to perform three
maximal isometric contractions. Patients took brief pauses between measurements. The maximal
value was recorded to the nearest 0.1 kg, and was used to compare with the 10th percentile of age- and
gender-dependent reference values [24]. If patients were unable to perform handgrip strength with
their dominant hand, the non-dominant hand was used.
2.6. Patient Outcomes
Patient outcome measures were collected 12 months post initial study date and were obtained
from the patient electronic medical record. This included mortality, number of hospital admissions
during the 12-month period and length of stay of hospital admissions.
2.7. Statistical Analysis
Data analysis was completed using IBM SPSS software V.25.0 for Windows. A significance level
of 5% was applied to detect statistical significance. For normally distributed continuous variables,
independent t-tests were applied to compare means between malnutrition categories. PG-SGA SF
values from 1 to 7 were each analysed to determine optimal cut-off values to determine malnutrition
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risk for this population. In order to compare the PG-SGA SF and GLIM with the reference instrument
(PG-SGA), sensitivity, specificity and positive and negative predictive values for the PG-SGA SF
and GLIM against PG-SGA were calculated and receiver operating characteristic (ROC) curves were
generated. Kappa coefficient was assessed to investigate the rate of agreement between PG-SGA SF
or GLIM and PG-SGA. To determine the validity of the PG-SGA SF, the professional standard 80%
for sensitivity and 60% for specificity were determined based on the literature [25,26]. The kappa
coefficient was interpreted based on the literature [27,28] as follows: <0 as poor agreement; 0.01–0.20 as
slight agreement; 0.21–0.40 as fair agreement; 0.41–0.60 as moderate agreement; 0.61–0.80 as substantial
agreement; and 0.81–1.00 as almost perfect agreement. The professional standard for kappa was
set to >0.60 [29]. Cox proportional hazards analyses were performed to determine the association
between malnutrition diagnoses and mortality 1 year after the audit date. Univariate as well as
multivariate analyses adjusted for gender, age (≤65 years vs. >65 years), obesity (BMI ≥ 30 kg/m2) and
diagnosis (breast cancer vs. other types of cancer) were performed on the basis of available literature.
The association between malnutrition diagnoses and hospital admissions (Y/N) and length of stay was
investigated by logistic and linear regression analysis, respectively (both univariate and multivariate,
adjusted for similar confounders).
3. Results
Out of 275 patients that were eligible, a total of 246 patients consented to participate in the study.
The mean age was 61.9 ± 13.1 years, and 182 (74%) patients were female. The most common cancer
diagnoses were breast (45%), gynaecological (13%) and colorectal (11%) (Table 2).
Table 2. Patient characteristics of 246 patients with cancer attending an ambulatory cancer care centre.
n (%)
Age 1 61.9 ± 13.1
Gender
Male 64 (26)
Female 182 (74)
BMI (WHO categories) 2
Underweight (≤18.5 kg/m2 for <65 years, <24 for ≥65 years) 30 (14)
Healthy weight (18.5–25 kg/m2 for <65 years, 24–31 for ≥65 years) 102 (47)
Overweight (≥25–30 kg/m2 for <65 years, >31 for ≥65 years) 53 (24)
Obese (≥30 kg/m2 for <65 years) 33 (15)
Type of cancer
Respiratory 21 (9)
Urogenital 15 (6)
Head and neck 1 (1)
Gynaecology 32 (13)
Breast 110 (45)
Haematology 21 (9)
Colorectal 27 (11)
Upper GI 11 (5)
Melanoma 7 (3)
Unknown primary 1 (1)
Emetogenicity of current cancer treatment 3
Low 125 (53)
Moderate 64 (27)
High 47 (20)
1 Average ± SD, 2 n = 218, 3 n = 236. BMI = body mass index; WHO = World Health Organization.
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3.1. Validity of Malnutrition Tools/Instruments
The MST had a sensitivity of 100% and a specificity of 90% (kappa: 0.737) when compared to the
reference tool PG-SGA.
The sensitivity and specificity for the different cut-off scores and percentiles of PG-SGA SF are
depicted in Table 3. The sensitivity was the highest when applying a cut-off score ≥3 for PG-SGA SF,
however cut-off scores ≥3, ≥4 and ≥5 all fulfilled the criteria deemed acceptable for validity. A PG-SGA
SF cut-off score ≥5 had the highest agreement and deemed most suitable when compared with the
reference PG-SGA, with a sensitivity of 89%, a specificity of 80% and a ‘moderate agreement’ (k = 0.493).
Table 3. Sensitivity and specificity of nutritional indices of malnutrition risk and malnutrition as
determined by reference standard Patient-Generated Subjective Global Assessment.
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Kappa
Malnutrition Risk
PG-SGA SF (≥3) 94 62 31 98 0.311
PG-SGA SF (≥4) 92 71 37 98 0.387
PG-SGA SF (≥5) 89 80 45 98 0.493
PG-SGA SF (≥3) and HGS < 10th percentile 21 95 44 87 0.208
PG-SGA SF (≥4) and HGS < 10th percentile 21 96 50 87 0.229
PG-SGA SF (≥5) and HGS < 10th percentile 21 96 50 87 0.229
Malnutrition
GLIM criteria (moderate, severe or both) 76 73 34 94 0.323
GLIM criteria and HGS < 10th percentile 19 96 43 87 0.186
PG-SGA SF Patient-Generated Subjective Global Assessment Short Form; HGS handgrip strength; GLIM Global
Leadership Initiative on Malnutrition; PPV positive predictive value; NPV negative predictive value.
When compared to the reference standard PG-SGA, malnutrition according to the GLIM criteria
had a sensitivity of 76%, specificity of 73% and a ‘fair agreement’ (k = 0.323). When adding handgrip
strength < 10th percentile of reference values, sensitivity and specificity for both PG-SGA SF and GLIM
declined to around 20% and 95–96%, respectively and kappa declined to approximately 0.2 (poor to
slight agreement).
3.2. Malnutrition Risk and Malnutrition
According to the MST, 60 patients (24%) were identified as at risk of malnutrition compared to 71
(31%) patients with PG-SGA SF ≥ 5 (Table 4). There were 32 (14%) patients with a handgrip strength
(HGS) cut-off score of <10th percentile. When handgrip strength < 10th percentile of reference values
was added to PG-SGA SF ≥ 5 the number of patients identified as at risk of malnutrition decreased to
14 (6%).
Table 4. Malnutrition risk as determined by PG-SGA SF.
At Risk Malnutrition n (%)
PG-SGA SF (≥1) 181 (79.4)
PG-SGA SF (≥2) 131 (57)
PG-SGA SF (≥3) 108 (47)
PG-SGA SF (≥4) 90 (39)
PG-SGA SF (≥5) 71 (31)
PG-SGA SF (≥6) 52 (23)
PG-SGA SF (≥7) 41 (18)
PG-SGA SF Patient-Generated Subjective Global Assessment Short Form.
According to the PG-SGA assessed by the dietitian, the number of patients who identified as
malnourished was 39 (16%), with 33 (13%) of those moderately (PG-SGA B) malnourished. According to
the GLIM criteria for the diagnosis of malnutrition; 77 (35%) out of 220 patients were identified as
Nutrients 2020, 12, 2287 7 of 13
malnourished (moderately, severely, or both). When handgrip strength was added to the GLIM criteria
(HGS < 10th percentile), malnutrition prevalence was reduced to 7% (n = 14).
Malnutrition according to the PG-SGA was identified across all BMI categories, with the lowest
percentage of malnutrition in obese patients. Cancer types with the highest rates of malnutrition were
respiratory (n = 21, 29%), haematology (n = 21, 24%) and colorectal cancer (n = 27, 22%). In patients
receiving chemotherapy agents with a moderate or high emetogenicity risk, more patients were
malnourished (24%) compared to patients receiving low emetogenicity risk agents (10%) (p = 0.002).
The most frequently reported nutrition impact symptom in the malnourished group was ‘no appetite’
(n = 23, 59%), followed by ‘things taste funny or have no taste’ (n = 18, 46%) and ‘fatigue’ (n = 12, 31%).
A reduced food intake in the past month was reported by 66 patients (29.5%). In malnourished
patients, a food intake less than usual was reported by 80% (n = 28), compared to only 20% (n = 38) in
well-nourished patients (p < 0.001).
3.3. Patient Experience
Table 5 displays data on patients’ experiences with self-completing the PG-SGA SF during the
2019 audit. A 95% completion rate was achieved (100 out of 105 questionnaires completed). According
to the questionnaire responses, 98% of patients indicated that the instructions to complete the tool
were clear (n = 101), and most found the questions easy to understand (n = 101, 97%). Furthermore,
81% of patients thought the questions did not take too long to complete (n = 100) with most reporting
it took five minutes or less to complete the PG-SGA SF (n = 100, 97%).
Table 5. Patient experience completing PG-SGA SF.
n n (%)
Questionnaires
105
Completed 100 (95%)
Not completed 4 (4%)
Partially completed 1 (1%)
The instructions to complete the self-completed
tool were clear
101
Strongly agree 47 (47%)
Agree 52 (52%)
Neutral 1 (1%)
Disagree 1 (1%)
Strongly disagree 0
I understood the questions
101
Strongly agree 52 (52%)
Agree 46 (46%)
Neutral 2 (2%)
Disagree 1 (1%)
Strongly disagree 0
Please estimate the time taken to complete the
questions
100Less than 3 min 61 (61%)
3–5 min 36 (36%)
More than 5 min 3 (3%)
The questions took too much time to complete
100
Strongly agree 6 (6%)
Agree 6 (6%)
Neutral 7 (7%)
Disagree 47 (47%)
Strongly disagree 34 (34%)
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3.4. Patient Outcomes
Multivariate analyses showed that malnutrition according to the GLIM criteria was associated
with a 2-fold increased 1-year mortality risk, and a 4-fold increased risk when adding handgrip strength
lower than the 10th percentile of reference value as a muscle strength parameter. However, these
associations were borderline statistically significant (Table 6). Severe malnutrition according to the
GLIM criteria was associated with increased mortality risk (HR 2.9, p = 0.019); this was not the case
for moderate malnutrition according to GLIM, or for moderate or severe malnutrition (GLIM) when
adding handgrip strength < 10th percentile of reference values.
Table 6. Associations between malnutrition diagnoses and 1-year mortality in patients with cancer
attending an ambulatory cancer care centre.
Malnutrition Diagnosis Model 1
1
HR (95% CI)
Model 2 1
HR (95% CI)
Model 3 1
HR (95% CI)
MST ≥ 2 2.554 (1.296; 5.032) 3.021 (1.339; 6.817) 3.392 (1.463; 7.865)p = 0.004
PG-SGA B or C 7.128 (2.982; 17.034) 7.305 (2.822; 18.908) 10.373 (3.752; 28.681)p < 0.001
GLIM-malnutrition 1.951 (0.930; 4.092) 2.186 (0.982; 4.867) 2.238 (1.004; 4.991)p = 0.049
GLIM-malnutrition + handgrip strength
< 10th percentile 2.952 (0.856; 10.178) 3.237 (0.882; 11.884)
4.136 (1.009; 16.958)
p = 0.049
GLIM: moderate malnutrition 1.053 (0.481; 2.304) 1.165 (0.518; 2.620) 1.166 (0.522; 2.606)p = 0.708
GLIM: moderate malnutrition +
handgrip strength < 10th percentile 4.048 (0.498; 32.928) 3.201 (0.377; 27.205)
3.642 (0.410; 32.349)
p = 0.246
GLIM: severe malnutrition 2.631 (1.187; 5.831) 2.575 (1.100; 6.031) 2.890 (1.193; 7.001)p = 0.019
GLIM: severe malnutrition + handgrip
strength < 10th percentile 2.908 (0.849; 9.963) 3.102 (0.854; 11.270)
3.796 (0.948; 15.200)
p = 0.059
PG-SA SF ≥ 3 3.091 (1.488; 6.422) 3.184 (1.436; 7.060) 3.099 (1.372; 7.000)p = 0.006
PG-SA SF ≥ 3 + handgrip strength <
10th percentile 1.477 (0.601; 3.632) 1.547 (0.569; 4.210)
1.570 (0.572; 4.310)
p = 0.381
PG-SA SF ≥ 5 3.195 (1.560; 6.543) 3.436 (1.535; 7.692) 3.512 (1.483; 8.318)p = 0.004
PG-SA SF ≥ 5 + handgrip strength <
10th percentile 1.477 (0.601; 3.632) 1.547 (0.569; 4.210)
1.570 (0.572; 4.310)
p = 0.381
Handgrip strength < 10th percentile 1.713 (0.735; 3.995) 1.913 (0.721; 5.076) 1.958 (0.729; 5.259)p = 0.183
HR hazard ratio; CI confidence interval. 1 Dependent variable: 1-y mortality, independent variables: Model 1:
malnutrition diagnosis (0/1), Model 2: malnutrition diagnosis (0/1), gender (female vs. male), age (≥65 vs. <65 y),
BMI (≥30 kg/m2 vs. <30 kg/m2), Model 3: malnutrition diagnosis (0/1), gender (female vs. male), age (>65 vs. ≤65
y), BMI (≥30 kg/m2 vs. <30 kg/m2), breast cancer vs. other types of cancer.
Malnutrition risk according to the PG-SGA SF (both with cut-off ≥3 and ≥5) was associated with a
1.6 or 3.5 increased mortality risk, respectively (p = 0.006 and p = 0.004). When including handgrip
strength, the PG-SGA SF was not associated with 1-year mortality risk.
The reference tools were both associated with 1-year mortality risk: hazard ratio (HR) 3.4
(p = 0.004) for MST ≥ 2, and HR 10.4 (p < 0.001) for PG-SGA B and PG-SGA C. No associations were
observed between number of hospital admissions or total length of stay in hospital during 1-year post
initial assessment.
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4. Discussion
Findings from this study demonstrate that the PG-SGA SF is an accurate, sensitive and specific
malnutrition screening tool in the ambulatory cancer care setting. This is consistent with other
studies [14,16] when compared to the full PG-SGA.
Our study identified that cut-off scores of ≥3, ≥4 and ≥5 all fulfilled criteria deemed acceptable
for validity, however a cut-off score of ≥5 had the highest agreement with the reference standard of
malnutrition according to PG-SGA. Optimal cut-off scores differ according to the literature, reporting
≥3 [16] and ≥6 [15] as optimal cut-off scores. This disparity may be due to different administration
methods (patient completed vs. clinician completed). In the current study the patient self-completed
the PG-SGA SF. This is more comparable to Gabrielson et al., reporting ≥6 as the optimal cut-off [15].
One reason for our lower cut-off score of ≥5 would be our formatting of the PG-SGA SF, which was the
removal of the activity box (box 4). This is a study limitation, however, which accounts for the lower
cut-off score.
When compared to MST, the PG-SGA SF identified more patients at risk of malnutrition (31%
vs. 24%). This could be explained by the inclusion of nutrition impact symptoms in the PG-SGA
SF. Nutrition impact symptoms were common in our cohort, with 29% of patients reporting at least
one symptom in the last two weeks. The PG-SGA SF provides valuable information on nutrition
impact symptoms, which alone succeeded in identifying patients at risk of malnutrition in previous
studies [16,30].
It has been hypothesized that identifying nutrition impact symptoms, especially early in the
cancer continuum, may facilitate pro-active malnutrition prevention [14]. For example, patients with
no significant weight loss reporting several nutrition impact symptoms are at risk of deterioration in
nutritional status and quality of life if they do not receive timely intervention.
Previous studies have indicated that patient-led screening is quick and easy for patients to
complete [18]. In our study, patients were provided simple instructions to self-complete the tool, with
the addition of patient experience questions in year two of the study. This was included to evaluate the
usability and acceptability of the patient completed tool within our local setting. Patient completed
PG-SGA SF was well accepted in our study with most indicating the questions easy to understand
and that it took five minutes or less to complete the tool. This is similar to a previous study in an
ambulatory cancer care setting where they found patient-led screening with the MST was reliable
and well accepted by patients [18]. The benefit of the PG-SGA SF over the MST is the additional
contributing factors associated with poor dietary intakes, enabling the delivery of the most efficient
nutrition intervention [6,31,32].
Malnutrition prevalence in our population differed greatly according to which tool was used,
with the GLIM criteria identifying two times the number of patients as malnourished compared to the
PG-SGA (35% vs. 16%). PG-SGA is a subjective diagnostic tool that is validated, reliable and widely
used in the oncology setting [33–35]. Whilst there is no gold standard for determining nutritional
status, for the purpose of our study we used PG-SGA as a primary reference tool to determine
the validity of GLIM criteria for malnutrition. When compared to this reference standard PG-SGA,
malnutrition according to the GLIM criteria had a sensitivity of 76%, specificity of 73% and a ‘fair
agreement’ (k = 0.323). This falls slightly short of the acceptable professional standard of 80% and
60%. The difference in prevalence rates between PG-SGA and GLIM criteria can be theorised by
the time frame of involuntary weight loss and the use of BMI. The PG-SGA classification is based
on 1-month weight loss percentage, whereas the GLIM criteria include weight loss up to 6 months
and beyond 6 months. This may account for the high prevalence according to GLIM, where patients
with a history of weight loss that have stabilised weight in the recent period may be classified as not
malnourished according to PG-SGA. Additionally, a low BMI as a phenotypic criterion can classify
patients as malnourished according to GLIM, whereas BMI is not used in the PG-SGA. There is
substantial variation in the use of low BMI as a phenotypic criterion for diagnosis of malnutrition and
further research on this is required [36].
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Furthermore, in our study a PG-SGA was only completed on patients who scored MST ≥ 2, with
all other patients assumed as PG- SGA A (well nourished), whereas GLIM criteria were assessed
for all patients. Finally, the PG-SGA is a subjective diagnostic tool, in contrast, GLIM is an objective
measurement which determines patients with malnutrition using objective data and cut-offs, and
not by clinician’s or patient’s judgement [22]. This means that the skill and experience of clinicians
may impact less on validity and reliability of the assessment when using the GLIM. For these reasons,
studies evaluating the validity of a malnutrition tool, should use an objective reference tool rather
than a subjective tool. The GLIM initiative targets the priority to adopt global consensus criteria so
that malnutrition prevalence interventions and outcomes can be compared throughout the world [22].
The consensus criteria targets adults in clinical settings, although not specifically for a disease state.
The GLIM criteria do not entail the robust detail of comprehensive nutrition assessment but provide a
malnutrition diagnosis that may be complemented by more comprehensive assessment, for example
the PG-SGA, to provide the basis for individualised treatment plans.
Handgrip strength is a non-invasive, quick and easy method to assess peripheral muscle strength
and has been proposed as an indicator of muscle wasting and malnutrition [36]. In cancer patients,
muscle wasting is particularly frequent and is associated with increased morbidity and mortality [37].
In fact, in a study in patients with advanced-stage cancer, 6-month mortality was higher amongst
malnourished as assessed by the SGA (Subjective Global Assessment) and GLIM criteria using HGS
(using 5th percentile cut-off) [38]. It should be kept in mind that hand grip strength is an indicator of
upper limb strength and muscle function only and despite its apparent predictive potential, it cannot
replace assessment of muscle mass by validated body composition techniques (dual energy x-ray
absorptiometry (DXA), bioelectrical impedance analysis (BIA), computed tomography (CT), magnetic
resonance imaging (MRI)). Muscle strength tools can be used as a supporting proxy [22]. According to
our findings, the addition of a handgrip strength test did not improve the recognition of malnutrition
risk when combined with PG-SGA SF. In fact, the sensitivity decreased to 21% (specificity 96%), and the
agreement with PG-SGA was poor. Furthermore, the addition of a handgrip strength test also did not
improve the recognition of malnutrition when combined to the GLIM criteria.
There is well-established evidence of the PG-SGA’s ability to predict clinical outcomes, such
as patient survival, postoperative complications, length of stay, quality of life and hospitalisation
costs [14]. Given the relatively new nature of the GLIM criteria, there are few studies investigating the
predictive ability in a cancer population. Recent studies found that malnutrition according to GLIM
criteria with the addition of hand grip strength in hospitalised cancer patients is associated with higher
mortality, specifically a 2–3-fold increase in mortality [38,39]. These findings are similar to our results,
which confirm that the GLIM criteria are sensitive to identify mortality risk. We note however, that it is
difficult to compare findings due to different populations, stages of disease and settings (ambulatory
vs. hospitalised), as well as differing hand grip strength references. Thus, more research is necessary to
investigate this association.
4.1. Limitations
The principal limitation of our study was removal of the activity box (box 4) from the PG-SGA
SF and therefore not using the tool as it was designed. This decision was based on findings by
Abbott et al., [16] showing that PG-SGA and additive score combinations of the first three boxes
(removing box 4) had higher sensitivity than the MST in ambulatory cancer patients.
Another major limitation of our study was that all patients with MST <2 were assumed as
well- nourished PG-SGA A. As this study was initially completed as part of the annual malnutrition
prevalence auditing, the usual procedure was to progress to PG-SGA only if MST ≥2. To enable analysis
of data, all patients with MST <2 were then assumed as PG-SGA A. This may have incorrectly labelled
patients as well-nourished when in fact they could have been malnourished.
Additionally, the study was completed over two separate weeks in two separate years with
slightly different methods applied. The addition of patient experience questions was only included in
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the second year which meant that this valuable information was only obtained from 40% of the study
population. Other limitations include our sample size of 246 patients, and heterogeneity of diagnoses.
4.2. Implications for Practice and Research
It is challenging to implement routine malnutrition screening in ambulatory cancer care settings.
Resources tend to be stretched, therefore screening tools should be quick and simple. We found that
the PG-SGA SF is a valid and suitable screening tool for cancer patients and is a good alternative
to the MST. The addition of a handgrip strength test did not add value to screening or diagnosing
malnutrition; it created extra work for clinicians and burden to patients and therefore has not been
implemented as standard care in our cancer centre. The benefit of the PG-SGA SF in being patient-led
aligns with core patient centred concepts and with engaging patients in the care process, and our data
showed a good acceptance and patient experience. PG-SGA SF and the GLIM criteria both predict
patient mortality, however, there needs to be more large-scale studies to validate the GLIM criteria and
compare to reference assessment tools, and body composition techniques.
5. Conclusions
The PG-SGA SF is an accurate, sensitive and specific malnutrition screening tool in the ambulatory
cancer care setting. It is patient completed which aligns with patient-centred concepts, and it is well
accepted by patients. The addition of a handgrip strength test did not add value, in fact, it reduced the
sensitivity in screening or diagnosing malnutrition. The GLIM criteria diagnosed a greater percentage
of malnutrition when compared to PG-SGA and the agreement of GLIM to this reference tool is fair.
The GLIM criteria should not replace the use of a comprehensive nutrition assessment and should be
used in parallel with established and validated tools such as PG-SGA.
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